Successful treatment with ustekinumab and vacuum‐assisted closure therapy in recalcitrant myelodysplastic syndrome‐associated pyoderma gangrenosum: case report and literature review

Click here for the corresponding questions to this CME article.

Saved in:
Bibliographic Details
Published inClinical and experimental dermatology Vol. 44; no. 1; pp. 116 - 119
Main Authors Nieto, D., Sendagorta, E., Rueda, J. M., Herranz, P.
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.01.2019
Subjects
Antibodies, Monoclonal, Humanized - therapeutic use
Case reports
Dermatologic Agents - therapeutic use
Humans
Immunotherapy
Literature reviews
Male
Middle Aged
Monoclonal antibodies
Myelodysplastic syndrome
Myelodysplastic syndromes
Myelodysplastic Syndromes - complications
Myelodysplastic Syndromes - drug therapy
Myelodysplastic Syndromes - pathology
Negative-Pressure Wound Therapy - instrumentation
Pyoderma
Pyoderma gangrenosum
Pyoderma Gangrenosum - complications
Pyoderma Gangrenosum - drug therapy
Pyoderma Gangrenosum - pathology
Skin diseases
Treatment Outcome
Ustekinumab - administration & dosage
Ustekinumab - therapeutic use
Vacuum
Online AccessGet full text

Cover

More Information
Summary:Click here for the corresponding questions to this CME article.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0307-6938
1365-2230
DOI:10.1111/ced.13679